14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026
COLL vs SIGA: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 20, 2026, Collegium Pharmaceutical, Inc. (COLL) is the stronger overall head-to-head candidate over SIGA Technologies Inc. (SIGA) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). COLL carries a Unified Composite Score of 31.5/100 (SELL) at $24.72 (3.5x Forward P/E, 22.9% operating margin), whereas SIGA carries 46.2/100 (HOLD) at $2.40 (2.3x Forward P/E, -14.2% operating margin).
Composite vs. Pillar Nuance: While SIGA currently prints a higher short-term Unified Composite Score (46.2/100 HOLD vs. COLL 31.5/100 SELL), COLL captures the overall institutional head-to-head verdict (8–2 matrix metrics and 5–1 across the 6 pillars) due to superior fundamental profitability (22.9% vs. -14.2% operating margin) and revenue trajectory (+3.3% vs. -49.7% YoY).
Technical & Structure Timing Caution: COLL is currently in a Breakdown options structure phase (RSI 53.8); meanwhile SIGA is in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 31.0). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Competes within the Drug Manufacturers - Specialty & Generic value chain with $188.3M market capitalization and -14.2% operating margin.
OpEx & R&D Reinvestment37.6% of Rev ($20M)
90D Engineering Disclosures0 Published
Investor FAQ COLL vs SIGA Key Questions & Quantitative Answers
As of Nov 20, 2026, Collegium Pharmaceutical, Inc. (COLL) is the stronger overall head-to-head candidate over SIGA Technologies Inc. (SIGA) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). COLL carries a Unified Composite Score of 31.5/100 (SELL) at $24.72 (3.5x Forward P/E, 22.9% operating margin), whereas SIGA carries 46.2/100 (HOLD) at $2.40 (2.3x Forward P/E, -14.2% operating margin). Composite vs. Pillar Nuance: While SIGA currently prints a higher short-term Unified Composite Score (46.2/100 HOLD vs. COLL 31.5/100 SELL), COLL captures the overall institutional head-to-head verdict (8–2 matrix metrics and 5–1 across the 6 pillars) due to superior fundamental profitability (22.9% vs. -14.2% operating margin) and revenue trajectory (+3.3% vs. -49.7% YoY). Technical & Structure Timing Caution: COLL is currently in a Breakdown options structure phase (RSI 53.8); meanwhile SIGA is in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 31.0). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
COLL leads the Growth & Scale pillar: COLL posts +3.3% YoY revenue growth and -29.0% YoY earnings growth on $815M TTM revenue (89.4% gross margin, 22.9% operating margin), compared with SIGA at -49.7% YoY revenue growth and -65.3% YoY earnings growth on $52M TTM revenue (23.4% gross margin, -14.2% operating margin). Across the 8-period historical trajectory (FY2018 to FY2025), COLL cumulative revenue shifted +178.6% while SIGA shifted -81.2%. In operating R&D and SG&A reinvestment, COLL deploys 66.5% of Rev ($542M) (0 90-day corporate R&D disclosures) versus 37.6% of Rev ($20M) (0 disclosures) for SIGA.
SIGA screens cheaper on headline valuation multiples. COLL trades at 3.5x Forward P/E, 23.1x Trailing P/E, 0.76x PEG, and 2.1x EV/Revenue (41.3% FCF margin), whereas SIGA trades at 2.3x Forward P/E, N/M Trailing P/E, 3.37x PEG, and 1.4x EV/Revenue (-22.1% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against COLL (13.4% ROE) versus SIGA (0.4% ROE) capital efficiency.
In options market volatility and institutional positioning, COLL carries 93.0% implied volatility (20th %ile, Compressed (<25th %ile)), a 0.14x (Call-Skewed) Put/Call open-interest ratio, ACCUMULATION on-balance volume, and sits in a BREAKDOWN options structure phase (0.10β · 34% Vol realized risk). By comparison, SIGA carries 94.8% implied volatility (6th %ile, Compressed (<25th %ile)), a 0.50x (Call-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a BREAKDOWN options structure phase (0.90β · 74% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.